Organon (OGN) EBT (2020 - 2026)

Organon's EBT history runs 7 years deep, the most recent figure standing at $213.0 million for Q1 2026.

• In Q1 2026, EBT rose 110.89% year-over-year to $213.0 million; the TTM figure through Mar 2026 stood at $537.0 million (down 20.09% YoY), while the FY2025 annual figure was $425.0 million, down 47.34% from the prior year.
• EBT was $213.0 million for Q1 2026 at Organon, up from -$148.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $562.0 million in Q4 2022 to a low of -$148.0 million in Q4 2025.
• Historically, EBT has averaged $217.1 million across 5 years, with a median of $235.0 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBT jumped 158.75% in 2024, then plunged 214.73% in 2025.
• A 5-year view of EBT shows it stood at $562.0 million in 2022, then plunged by 81.49% to $104.0 million in 2023, then advanced by 24.04% to $129.0 million in 2024, then slumped by 214.73% to -$148.0 million in 2025, then surged by 243.92% to $213.0 million in 2026.
• The last three EBT figures came in at $213.0 million (Q1 2026), -$148.0 million (Q4 2025), and $243.0 million (Q3 2025), per Business Quant data.